MBMustafa Bayraktar

Mustafa Bayraktar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mustafa Bayraktar has a total of 181 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role of Endocan Level in Determining Large and Small Vessel Occlusion in Acute Ischemic Stroke

    by Erdal Tekin, Muhammet Çelik, Fatma Tortum, Ali Gür, İbRahim Özlü, Mehmet Nuri Koçak, Özcan AğyürEk, Mustafa Bayraktar

    Background: Stroke is a clinical condition in which blood flow to a brain area is interrupted by occlusion or hemorrhage. At present, the diagnosis and treatment of stroke are based on the use of biochemical markers and imaging methods. The degree of inflammation in the vessel wall may be reflected by changes in endocan levels. The aim of this study was the investigation of the role of endocan blood levels in the determination of large- and small-vessel occlusion in acute ischemic stroke. Methods: This was a prospective, single-center clinical study. Sociodemographic characteristics, physical examination, laboratory findings, and endocan levels were recorded. Patients with ischemic stroke were categorized as large-vessel occlusive (LVO) or small-vessel occlusive (SVO) on computed tomography (CT) angiography. Blood endocan levels were compared between the 2 groups. Results: A total of 110 patients were included in the study; the mean age of these patients was 69.2 years and 50.5% were male. Large-vessel occlusive was present in 33.3% (n = 31) of these patients, and endocan levels were higher in the LVO group but without statistical significance (P > .05). Modified Rankin Score was higher in the LVO group while Glasgow Coma Score was lower and both were statistically significant (P < .001). The area under the receiver-operating characteristic (ROC) curve for troponin was 0.762 and statistically significant (P = .001). Conclusion: Serum endocan levels did not differ significantly between LVO patients and controls. However, more research is needed to determine how significant these high endocan levels are in diagnosing major artery disease. Cite this article as: Tekin E, Çelik M, Tortum F, et al. The role of endocan level in determining large and small vessel occlusion in acute ischemic stroke. Eurasian J Med. 2026, 58(2), 1094, doi: 10.5152/ eurasianjmed.2026.251094.

  • Open Access

    Lactate dehydrogenase to albumin ratio as a convenient parameter for predicting the severity of Behçet disease: a cross-sectional study

    by Erdal Pala, Mustafa Bayraktar

    We investigated whether the ratio of lactate dehydrogenase (LDH) to albumin could be used as a diagnostic marker for Behçet’s disease compared t


  • Open Access

    Screening patients with metabolic syndrome for risk of obstructive sleep apnea: the syndrome Z

    by Hacı Ahmet Aydemir, Mustafa Bayraktar

    Aims: Syndrome Z is defined as the coexistence of obstructive sleep apnea (OSA) and metabolic syndrome. As family medicine takes on the role of preventive medicine, syndrome Z is gaining importance in primary care. We aimed to determine the prevalence of syndrome Z in primary care by examining the risk of OSA in individuals with metabolic syndrome. Methods: A cross-sectional study of patients diagnosed with metabolic syndrome according to NCEP-ATP III criteria was conducted at the Family Health Center. Patients' anthropometric measurements (waist circumference, neck circumference, height, and weight) were recorded. OSA risk assessment scales included the Berlin and STOP-BANG questionnaires, which have been shown in studies to be more sensitive tests and were therefore selected for use in our study. Results: Of 156 participants, 37.8% (n=59) were at high risk for OSA on both questionnaires. According to STOP-BANG, 57.4% of men and 31.6% of women were at high risk, which was statistically significant. No association was found between OSA and diabetes, hypertension, and dyslipidemia. However, in both questionnaires, obesity and high body mass index significantly increased the risk of OSA. The area under the curve (AUC) was 0.649 with a specificity of 80.6% using a cut-off of 34.5 kg/m² for BMI. Conclusion: Obese individuals with metabolic syndrome should be assessed for syndrome Z in primary care settings and preventive services should be offered to those at risk.


  • Open Access

    Post–Vaccination Side Effects After the First Dose of Inactive CoronaVac® in Healthcare Personnel in Türkiye

    by Mustafa Bayraktar, Esra Çınar Tanrıverdi, Zülal Özkurt, Pınar Gürsoy Güven

    This study aimed to investigate the side effects observed in healthcare personnel who were the first to receive the first dose of inactivated CoronaVac® vaccine in Turkey. Healthcare personnel vaccinated for the first time with the inactivated CoronaVac® vaccine between February and March 2021 during the initial administration of COVID-19 vaccines were asked to respond to an online questionnaire to investigate local and systemic side effects they observed after vaccination. Of the 2601 participants included in the study, 72.5% (n=1886) were female, and 27.5% (n=715) were male. The mean age was 37.6±11.7 years. Regarding side effects, 39.9% had at least one local side effect, and 54.4% had at least one systemic side effect. These side effects lasted for 4.0±2.6 days on average. The three most common local side effects were local pain (38.1%), swelling (1.9%) and redness (1.5%), whereas the most common systemic side effects were weakness (28.4%), headache (27.9%), fatigue (26%), myalgia (18.2%), and arthralgia (11.8%). Systemic side effects were significantly more common in females, nurses and midwives, younger age groups, and people without a history of chronic disease (P

  • Open Access

    Third-hand smoke perception and awareness among medical students: a survey study

    by Aysun Aras, Mustafa Bayraktar

    Third-hand smoke (THS) is tobacco smoke impurities that adhere to indoor materials such as clothing, dust, and surfaces and are released into the air. It is a major public health concern that, if unaddressed, could cause future harm. The aim of this study was to assess medical students’ knowledge of THS and to increase awareness. In March and April 2023, students enrolled in the medical programs at the School of Medicine for the 2022–2023 academic year were contacted using an online Google survey method and asked to complete the survey questions. The survey included questions on participants’ sociodemographic characteristics and the Beliefs about Third-Hand Smoke Scale (BATHS-T). The median age of the 351 students who voluntarily participated in the study was 20.0 (IQR = 2.0) years, 55.3% were female and 16% were smokers. The mean score of the answers given by the participants to the scale questions asking their level of knowledge about third-hand smoke was 35.3 ± 5.9. The least known question was “cigarette smoke particles can stay in a room for weeks”. The most frequently answered question was “breathing the air in a room where people smoked yesterday can damage the health of babies and children”. Scale scores were significantly higher for participants who did not have smokers living in their home, who did not allow smoking in their home, and who reported having information about passive smoking. Medical students had sufficient knowledge and awareness of third-hand smoke. Third-hand smoke should be included in training to increase knowledge and awareness of medical students as part of preventive medicine practice.


  • Open Access

    Changes in Smoking Behavior in the COVID-19 Pandemic: A Single Center Study in Family Practice

    by Kamber Kaşali, Mehmet Doğan, Hacı Ahmet Aydemir, Mustafa Bayraktar

    Objective: There are controversial studies on smoking addiction in the COVID-19 pandemic. While some studies show increased tobacco use during the pandemic, others report increased smoking cessation attempts. This study examined changes in tobacco use and quit intentions during the COVID-19 pandemic compared to pre-pandemic. Methods: A cross-sectional study was designed and three groups were formed by including patients over 18 years of age, who were smokers, and who presented to the Education Family Health Center and had RT-PCR test results for COVID-19. Among these patients, patients with COVID-19 symptoms and complaints and positive RT-PCR test results constituted the COVID-19 positive group, patients who were COVID-19 negative but isolated due to their contacts constituted the contact group, and healthy people without any COVID-19 contact and symptoms constituted the healthy group. Demographic characteristics, smoking status before the COVID-19 pandemic, change in smoking status after COVID-19 test result or contact, and Fagerström nicotine dependence test results were compared. Results: Of the total 131 participants enrolled in the study, 70 were in the healthy group, 31 were in the COVID-19 negative group, and 30 were in the COVID-19 positive group. Men were predominant in three groups (60%, 83.9%, and 73.3% in normal, COVID-19-neg, and COVID-19-positive groups, respectively) with a small significant difference (p=0.048). The mean ages were 41.09±12.85, 38.21±11.69, and 39.47±11.66 years in the healthy, COVID-19 negative, and COVID-19 positive groups, respectively, with no significant difference (p>0.05). Fagerström dependence scores were 1.82±1.05, 1.53±0.86, and 1.40±0.72 in the healthy, COVID-19 negative, and COVID-19 positive groups, respectively, and were not statistically different (p>0.05). Smoking prevalence decreased by 1.13 (±4.17) cigarettes per day in the healthy group, by 3.97 (±5.31) cigarettes in the COVID negative group, and by 10.14 (±7.86) cigarettes in the COVID positive group, with a statistically significant decrease in smoking prevalence in all three groups (p

  • Open Access

    Relationship between C-reactive protein/albumin ratio and mucocutaneous symptom frequency and disease severity in Behçet’s disease

    by Erdal Pala, Mustafa Bayraktar

    Background/aim: There is no specific marker that can be applied to determine the severity of Behçet’s disease. The aim of this study is to investigate the potential of C-reactive protein (CRP)/albumin (CAR) ratio as a tool for assessing the severity of Behçet’s disease.Materials and methods: A retrospective crosssectional study was conducted by examining hospital archives. The CRP and albumin levels of Behçet’s disease patients who presented to our dermatology clinic over a three-year period from February 2020 to February 2022 were included, along with the identical laboratory parameters in the control group. The CAR ratio was calculated and statistically compared across different clinical features of the disease and with the control group.Results: Of the 97 patients with Behçet’s disease, 70.1% (n = 68) were female and the median age was 36.0 years (IQR = 20.5), whereas of the 53 control subjects, 77.4% (n = 41) were female and the median age was 35.0 years (IQR = 19.0). There was no statistically significant difference in sex or age between the groups (p > 0.05). The levels of CRP and CAR were found to be significantly elevated in patients with Behçet’s disease compared to the control group (both p < 0.001). According to the ROC analysis, the area under the curve (AUC) of CRP level and CAR were found to be 0.784 (95%CI: 0.710–0.859), and 0.786 (95%CI: 0.712–0.861), respectively. The cut-off value for CRP was determined as 1.485, whereas for CAR it was 0.324. As the severity of Behçet’s disease increased, there was a statistically significant increase in the CAR level (p < 0.001). The severity of Behçet’s disease was statistically significantly associated with a high CAR level.Conclusion: CAR can be used as a quick and easily calculated parameter to assess the severity of Behçet’s disease.


  • Open Access

    The potential association between herpes zoster and COVID-19 vaccination

    by Erdal Pala, Mustafa Bayraktar, Rümeysa Calp


  • Open Access

    Use of bee venom in preventive medicine: An experimental hepatic encephalopathy study in rats

    by Mustafa Bayraktar, Ahmet Hacımüftüoğlu, Ufuk Okkay, Mehmet Nuri Koçak, Murat Kösedağ, Erdal Tekin, Muhammet Çelik, Irmak Ferah Okkay, Cemil Bayram, Muhammet Sait Ertuğrul, et al.

    Objectives: Bee venom is used for medicinal purposes, including the treatment of neurological and liver diseases, but its use as a primary health care approach for preventive purposes requires further exploration. The aim of this study was to provide the first investigation into the possible protective effects of bee venom against hepatic encephalopathy, a serious neurodegenerative disease.Materials and Methods: An experimental animal study was conducted in which healthy albino Sprague–Dawley rats were randomized into three groups: healthy, control and bee venom groups. All rats were tested for locomotor activity at the beginning and end of the study. No intervention was made in the healthy group, whereas hepatic encephalopathy was induced in the control and bee venom groups by the administration of thioacetamide (TAA) (200 mg/kg/day). The bee venom group also received bee venom (5 mg/kg/day) subcutaneously every day for 14 days prior to the TAA administration.Results: The results for the final locomotor activity tests were statistically better in the bee venom group than in the control group, supporting a beneficial effect of prophylactic bee venom application. Blood ammonia levels and liver weights, determined as indicators of inflammation, were lower in the bee venom group than in the control group and were close to levels in the healthy group, but not statistically significant.Conclusions: Bee venom administration has protective effects against the development of hepatic encephalopathy and offers a promising therapeutic opportunity in preventive medicine.